AI Terminal
Kingfisher PLC
Transaction in Own Shares • Mar 30, 2023
4675_rns_2023-03-30_fe7457ce-fb55-4fd3-a97a-bdd1e301f3eb.html
Transaction in Own Shares
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 6743U
Kingfisher PLC
30 March 2023
KINGFISHER PLC
Transaction in own shares
30 March 2023: Kingfisher plc, ISIN: GB0033195214 (the "Company", "Kingfisher") announces that on 29 March 2023 it purchased for cancellation the following number of ordinary shares of 15 5/7 pence each from BNP Paribas Exane, Intermediary Code: 969500UP76J52A9OXU27 ("BNP Paribas Exane") as part of its £300 million capital return programme announced on 23 May 2022 (the "Programme"). All shares were purchased by Kingfisher from BNP Paribas Exane as an "on-exchange" transaction in accordance with the rules of the London Stock Exchange.
| Date of purchase: | 29 March 2023 |
| Total number of shares purchased: | 44,550 |
| Volume Weighted Average price paid per share: | GBp 252.5535 |
| Highest price paid per share: | GBp 255.2000 |
| Lowest price paid per share: | GBp 249.1000 |
To date, Kingfisher has purchased 19,781,041 ordinary shares in aggregate for cancellation from BNP Paribas Exane in connection with the third tranche of the Programme. Kingfisher also previously purchased 30,583,514 ordinary shares in aggregate for cancellation from Goldman Sachs International and 31,306,331 ordinary shares in aggregate for cancellation from Credit Suisse International in connection with its execution of the first and second tranches, respectively, of the Programme.
A schedule of individual trades carried out by BNP Paribas Exane as principal in connection with the above purchases is set out below.
Schedule of Purchases - Aggregate Information
| Trading Venue | Number of Shares | Volume Weighted Average Price paid per share |
| XLON | 43,749 | GBp 252.5981 |
| BATE | 467 | GBp 250.4865 |
| TRQX | 334 | GBp 249.6000 |
Schedule of Purchases - Individual Transactions
| Price GBp | Time of each trade on 29 March 2023 (UTC) | Trading venue | Quantity | Transaction Reference Number |
| 251.0 | 07:01:32 | XLON | 1,533 | 00340822105EXPA1 |
| 249.6 | 07:16:23 | TRQX | 334 | 00340825339EXPA1 |
| 249.6 | 07:16:23 | XLON | 69 | 00340825340EXPA1 |
| 249.6 | 07:16:23 | BATE | 347 | 00340825341EXPA1 |
| 249.9 | 07:35:34 | XLON | 1,633 | 00340828925EXPA1 |
| 249.9 | 07:35:34 | XLON | 1,109 | 00340828926EXPA1 |
| 249.1 | 07:57:26 | XLON | 3,576 | 00340832451EXPA1 |
| 250.1 | 08:43:38 | XLON | 2,908 | 00340840749EXPA1 |
| 250.5 | 09:09:40 | XLON | 2,279 | 00340846192EXPA1 |
| 252.6 | 09:40:50 | XLON | 2,144 | 00340852510EXPA1 |
| 253.7 | 10:20:17 | XLON | 2,525 | 00340860049EXPA1 |
| 253.6 | 10:25:40 | XLON | 3,075 | 00340860951EXPA1 |
| 253.3 | 10:58:25 | XLON | 4,076 | 00340866802EXPA1 |
| 253.6 | 11:41:19 | XLON | 1,111 | 00340873188EXPA1 |
| 253.6 | 11:41:19 | XLON | 900 | 00340873189EXPA1 |
| 255.2 | 12:18:45 | XLON | 1,170 | 00340878676EXPA1 |
| 255.2 | 12:18:45 | XLON | 899 | 00340878679EXPA1 |
| 254.7 | 12:33:02 | XLON | 580 | 00340881802EXPA1 |
| 254.7 | 12:33:02 | XLON | 2,038 | 00340881803EXPA1 |
| 254.4 | 12:38:00 | XLON | 948 | 00340882764EXPA1 |
| 254.4 | 12:38:00 | XLON | 1,224 | 00340882765EXPA1 |
| 253.8 | 13:06:39 | XLON | 2,215 | 00340888884EXPA1 |
| 253.7 | 13:29:38 | XLON | 2,895 | 00340894757EXPA1 |
| 253.5 | 14:06:07 | XLON | 691 | 00340908412EXPA1 |
| 253.5 | 14:06:07 | XLON | 1,845 | 00340908413EXPA1 |
| 253.0 | 14:37:19 | XLON | 1,268 | 00340919381EXPA1 |
| 253.0 | 14:41:24 | BATE | 60 | 00340920476EXPA1 |
| 253.0 | 15:00:46 | XLON | 1,038 | 00340927921EXPA1 |
| 253.1 | 15:04:58 | BATE | 60 | 00340929371EXPA1 |
| Contacts: | Tel: | Email: |
| Company Secretary | +44 (0) 77 6880 6248 | [email protected] |
| Investor Relations | +44 (0) 20 7644 1082 | [email protected] |
| Treasury | +44 (0) 79 7767 8200 | [email protected] |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
POSEAKDNAEPDEFA